One sign that workstation consolidation is becoming a reality in the clinical laboratory: two of the nation's largest group purchasing organizations (GPOs) say they are rethinking the way they contract for certain laboratory segments, notably clinical chemistry and immunoassay. Novation Inc., the year-old GPO formed from the merger of VHA Inc. and University HealthSystem Consortium, is considering in the future combining its now separate contracts for clinical chemistry and immunoassay equipment, not only because of technological innovations, but also because of the overwhelming need to drive efficiencies for laboratory operations.
And Premier Inc. is also reconsidering its approach to diagnostics. To this end, it is planning for the first...
Read the full article – start your free trial today!
Join thousands of industry professionals who rely on In Vivo for daily insights
- Start your 7-day free trial
- Explore trusted news, analysis, and insights
- Access comprehensive global coverage
- Enjoy instant access – no credit card required
Already a subscriber?